Dante Rotili

Pubblicazioni

Titolo Pubblicato in Anno
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 2023
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3 CANCER COMMUNICATIONS 2023
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress ANTIOXIDANTS 2023
Hydrophilic gold nanoparticles as Anti-PD-L1 antibody carriers. Synthesis and interface properties PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION 2022
Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications PHYSICA MEDICA 2022
Biochemical functions and clinical characterizations of the sirtuins in diabetes-induced retinal pathologies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription NUCLEIC ACIDS RESEARCH 2022
The Nitrobenzoxadiazole Derivative NBDHEX Behaves as Plasmodium falciparum Gametocyte Selective Inhibitor with Malaria Parasite Transmission Blocking Activity PHARMACEUTICALS 2022
A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2022
Neuroprotective effects of PARP inhibitors in Drosophila models of Alzheimer’s disease CELLS 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2022
Sirtuin modulators: past, present, and future perspectives FUTURE MEDICINAL CHEMISTRY 2022
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni ACS INFECTIOUS DISEASES 2022
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5 JOURNAL OF MEDICINAL CHEMISTRY 2022
Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells CANCER GENE THERAPY 2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduced Viability in Worm Larval and Adult Stages CHEMMEDCHEM 2022
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics MOLECULAR METABOLISM 2022
Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells CANCER GENE THERAPY 2022
Modulation of virulence-associated traits in Aspergillus fumigatus by BET Inhibitor JQ1 MICROORGANISMS 2022
Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer CANCERS 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma